Differential extraction of endogenous and exogenous 25-OH-vitamin D from serum makes the accurate quantification in liquid chromatography-tandem mass spectrometry assays challenging.
BACKGROUND
Extraction followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis is the method of choice when it comes to the accurate quantification of 25-OH-vitamin D in blood samples. It is generally assumed that the addition of exogenous internal standard allows for the determination of the endogenous analyte concentration. In this study we investigated the extraction properties of endogenous and exogenous 25-OH-vitamin D.


METHODS
Eight samples were used for the evaluation of the extraction procedure and 59 patients' samples for a method comparison. The methanol-to-sample ratio (v/v) and the sample-to-hexane ratio (v/v) were varied and the LC-MS/MS signals of endogenous 25-OH-vitamin D3, spiked 25-OH-vitamin D2 and internal standard of the extracts recorded. The optimized 'in-house' LC-MS/MS assay was compared to two automated chemiluminescence immunoassays from DiaSorin and Abbott.


RESULTS
Mathematical analysis of the data revealed a differential extraction of endogenous 25-OH-vitamin D3, spiked 25-OH-vitamin D2 and non-equilibrated internal standard. Exogenous 25-OH-vitamin D can be measured accurately if a definite methanol-to-sample ratio is used. Endogenous 25-OH-vitamin D is affected by critical quantification issues due to a differential slope in the extraction profile. The actual 25-OH-vitamin D concentration can be one-third above the measured extractable concentration. Results confirm that the 'in-house' LC-MS/MS assay provides reproducible 25-OH-vitamin D results.


CONCLUSIONS
Discordant concentrations of 25-OH-vitamin D from LC-MS/MS assays can be caused by selection of suboptimal extraction conditions. Furthermore, a different sample pretreatment or solvent extraction system may result in a different dissociation and extraction yield of endogenous 25-OH-vitamin D and therefore contribute to variations of LC-MS/MS results.
Steroid and Immunobiochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand ulrich.lankes@cdhb.health.nz.
Ulrich
U
Lankes
Steroid and Immunobiochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
Peter A
PA
Elder
Steroid and Immunobiochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
John G
JG
Lewis
Clinical Biochemistry, Canterbury Health Laboratories, Christchurch, New Zealand.
Peter
P
George
D015652:25-Hydroxyvitamin D 2 / Q000097:blood*; D015982:Bias; D002112:Calcifediol / Q000097:blood*; D016022:Case-Control Studies; D002853:Chromatography, Liquid / Q000592:standards*; D006432:Hemochromatosis / Q000097:blood; D006586:Hexanes; D006801:Humans; D007118:Immunoassay; D059625:Liquid-Liquid Extraction / Q000592:standards*; D000432:Methanol; D012015:Reference Standards; D012680:Sensitivity and Specificity; D012997:Solvents; D053719:Tandem Mass Spectrometry / Q000592:standards*
D006586:Hexanes; D012997:Solvents; D015652:25-Hydroxyvitamin D 2; D002112:Calcifediol; D000432:Methanol
25-OH-vitamin D; automated immunoassays; extraction; mass spectrometry